The People's Daily exposed fraud: Not long ago, springer Publishing Group, a well-known academic publishing institution, announced that it had revoked 65,438+007 articles from China published in its journal Tumor Biology from 2065,438+02 to 2065,438+06. According to statistics, these papers involve 77 units, including Fudan University, Zhejiang University, Peking Union Medical College Hospital, China-Japan Friendship Hospital and other well-known universities and medical institutions. The retraction not only reflects the disadvantages of the paper-oriented evaluation system, but also exposes the long-term lack of scientific research integrity culture in China.

The problem of evaluation system can't cover up the "right and wrong" of fraud.

20 15 In March, British Modern Biology Publishing Group announced that it had revoked 43 published papers, of which 4 1 came from Chinese mainland. In the same year, springer Publishing Group announced the withdrawal of 64 papers published by China authors in its 10 academic journal. An Nuojie, president of springer Publishing Group in Greater China, said that Tumor Biology checked all papers published on 20 12-20 16 by using the false peer review information obtained in the retraction incident on 20 15, and found that these papers were suspected of fraud.

People's Daily exposes fraud, academic fraud can't stop, and there is no lower limit for fraud (Figure)

Studies have shown that medical papers account for about half of the total number of papers in the world. The output of medical papers is large, but the overall quality is not high. A survey on 20 16 shows that China has become the largest country in the output of OA (open access) papers, but the number of papers published by Chinese authors in OA journals with poor reputation and low influence is huge. It is pointed out that in 20 15 years, the amount of APC (paper processing fee) paid by OA journals included in SCI in China ranked first. Jiang, director of the Department of Science History at Shanghai Jiaotong University, said that some journals with low influence and not serious are too commercialized, while China values the papers published by foreign journals, which can be described as "one is willing to fight and one is willing to suffer".

The People's Daily exposed fraud: Not long ago, springer Publishing Group, a well-known academic publishing institution, announced that it had revoked 65,438+007 articles from China published in its journal Tumor Biology from 2065,438+02 to 2065,438+06. According to statistics, these papers involve 77 units, including Fudan University, Zhejiang University, Peking Union Medical College Hospital, China-Japan Friendship Hospital and other well-known universities and medical institutions. The retraction not only reflects the disadvantages of the paper-oriented evaluation system, but also exposes the long-term lack of scientific research integrity culture in China.

The problem of evaluation system can't cover up the "right and wrong" of fraud.

20 15 In March, British Modern Biology Publishing Group announced that it had revoked 43 published papers, of which 4 1 came from Chinese mainland. In the same year, springer Publishing Group announced the withdrawal of 64 papers published by China authors in its 10 academic journal. An Nuojie, president of springer Publishing Group in Greater China, said that Tumor Biology checked all papers published on 20 12-20 16 by using the false peer review information obtained in the retraction incident on 20 15, and found that these papers were suspected of fraud.

Studies have shown that medical papers account for about half of the total number of papers in the world. The output of medical papers is large, but the overall quality is not high. A survey on 20 16 shows that China has become the largest country in the output of OA (open access) papers, but the number of papers published by Chinese authors in OA journals with poor reputation and low influence is huge. It is pointed out that in 20 15 years, the amount of APC (paper processing fee) paid by OA journals included in SCI in China ranked first. Jiang, director of the Department of Science History at Shanghai Jiaotong University, said that some journals with low influence and not serious are too commercialized, while China values the papers published by foreign journals, which can be described as "one is willing to fight and one is willing to suffer".